Quarterly Transactions Made in Enlivex Therapeutics Ltd. (ENLV)
This table provides information about the institutional ownership of Enlivex Therapeutics Ltd. (ENLV). The information is specifically focused on institutions that hold shares of Enlivex Therapeutics Ltd..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q2 2021 | 42,666 | 94,477 | 137,143 | 145,621 | 45,690 | 191,311 | -54,168 | |
| Q3 2021 | 15,359 | 65,090 | 80,449 | 173,285 | 11,080 | 184,365 | -103,916 | |
| Q4 2021 | 32,202 | 17,669 | 49,871 | 236,972 | 17,299 | 254,271 | -204,400 | |
| Q1 2022 | 154,382 | 73,871 | 228,253 | 20,972 | 36,582 | 57,554 | 170,699 | |
| Q2 2022 | 23,949 | 4,645 | 28,594 | 141,686 | 80,797 | 222,483 | -193,889 | |
| Q3 2022 | 31,783 | 81,012 | 112,795 | 9,868 | 140 | 10,008 | 102,787 | |
| Q4 2022 | 37,594 | 406 | 38,000 | 19,955 | 0 | 19,955 | 18,045 | |
| Q1 2023 | 20,251 | 0 | 20,251 | 14,800 | 0 | 14,800 | 5,451 | |
| Q2 2023 | 7,999 | 290 | 8,289 | 56,664 | 0 | 56,664 | -48,375 | |
| Q3 2023 | 2,505 | 1 | 2,506 | 21,996 | 0 | 21,996 | -19,490 | |
| Q4 2023 | 7,588 | 32,692 | 40,280 | 232,564 | 65,000 | 297,564 | -257,284 | |
| Q1 2024 | 158,491 | 25,485 | 183,976 | 594 | 0 | 594 | 183,382 | |
| Q2 2024 | 174,572 | 1,738,446 | 1,913,018 | 12,257 | 0 | 12,257 | 1,900,761 | |